Table 6 Stratified analysis of LINC00687 polymorphism rs2795025 and prognosis of GC
From: lncRNA polymorphism affects the prognosis of gastric cancer
rs2795025 | ≦65 | >65 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stages I–III | Stage IV | Stages I–III | Stage IV | |||||||||
N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | |
Codominance | ||||||||||||
 TT | 46 | 73.67 | 1 | 19 | 10.00 | 1 | 81 | 157.29 | 1 | 56 | 9.00 | 1 |
 TC | 35 | 106.04 | 1.157 (0.525–2.554) | 9 | 21.00 | 0.696 (0.282–1.717) | 38 | 75.00 | 0.901 (0.475–1.709) | 32 | 8.00 | 0.860 (0.538–1.374) |
 CC | 9 | 73.00 | 1.446 (0.406–5.151) | 2 | 4.00 | 5.911 (1.103–31.671) | 8 | 27.00 | 1.936 (0.675–5.553) | 9 | 11.00 | 1.087 (0.503–2.348) |
Dominant model | ||||||||||||
 TT | 46 | 73.67 | 1 | 19 | 10.00 | 1 | 81 | 157.29 | 1 | 56 | 9.00 | 1 |
 TC+CC | 44 | 73.00 | 1.209 (0.576–2.540) | 11 | 19.00 | 0.872 (0.380–2.002) | 46 | 75.00 | 1.029 (0.572–1.850) | 41 | 9.00 | 0.901 (0.584–1.391) |
Recessive model | ||||||||||||
 TT+TC | 81 | 103.76 | 1 | 28 | 13.00 | 1 | 119 | 81.00 | 1 | 88 | 8.00 | 1 |
 CC | 9 | 73.00 | 1.364 (0.400–4.648) | 2 | 4.00 | 6.611 (1.257–34.775) | 8 | 27.00 | 1.996 (0.707–5.634) | 9 | 11.00 | 1.148 (0.541–2.437) |